Cor Innovations is developing a revolutionary device to prevent congestive heart failure.
Congestive heart failure (CHF) is a devastating and costly disease affecting over 8.5 million Americans. Of the 1.2 million Americans who suffer a heart attack each year, 30% will develop CHF. Annual expenditures to treat CHF exceed $30 billion. Cor Innovations is currently developing a much needed, paradigm shifting minimally-invasive and biodegradable device to prevent heart dilation and progression to CHF following a heart attack.